National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 7) (PB 68 of 2017) (Cth)

PB 68 of 2017

National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 7)

National Health Act 1953

I, ROWENA SIERANT, Assistant Secretary (Acting), Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated         28 August 2017

ROWENA SIERANT

Assistant Secretary (Acting)

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 7).

(2)   This Determination may also be cited as PB 68 of 2017.

1. Commencement

This Determination commences on 1 September 2017.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Icatibant

Insert

Idelalisib

[2]     Schedule 1, after item dealing with Peginterferon Beta-1a

Insert

Pegvisomant